Combining polygenic risk scores to understand genetic liability to physical-mental health multimorbidity in UK Biobank.

IF 3.2 2区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Daniel Stow, Ruby S M Tsang, Ioanna K Katzourou, Jack F G Underwood, Peter Holmans, Inês Barroso, Hilary Martin, Marianne B M van den Bree, Sarah Finer, Nicholas J Timpson
{"title":"Combining polygenic risk scores to understand genetic liability to physical-mental health multimorbidity in UK Biobank.","authors":"Daniel Stow, Ruby S M Tsang, Ioanna K Katzourou, Jack F G Underwood, Peter Holmans, Inês Barroso, Hilary Martin, Marianne B M van den Bree, Sarah Finer, Nicholas J Timpson","doi":"10.1093/hmg/ddag012","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity, also known as multiple long-term conditions, is a major public health concern. Internalising and CardioMetabolic MultiMorbidity (ICM-MM) is a common form of mental-physical health multimorbidity, yet its genetic predisposition is largely unknown. We examined the polygenic nature of ICM-MM by assessing single trait-specific polygenic risk scores (PRSTRAIT) and whether combining them could increase the proportion of variance in liability to ICM-MM explained by genetic variation.</p><p><strong>Methods: </strong>We developed PRSTRAIT using PRS-CS and summary statistics from the largest trait-specific GWAS excluding UK Biobank (UKB). We evaluated PRSTRAIT on ICM-MM risk in 206 452 UKB participants (n = 39 311 (19.0%) with ICM-MM) using logistic regression adjusted for gender and 10 genetic principal components, defining ICM-MM as lifetime occurrence of: ≥1 internalising (depression, anxiety, somatoform disorder) traits AND ≥ 1 cardiometabolic traits (type 2 diabetes, obesity, hypertension, dyslipidemia, chronic kidney disease). We used elastic net regression in a 50% training sample to generate ICM-MM-PRSTRAIT: a weighted combination of PRSTRAIT targeting ICM-MM.</p><p><strong>Results: </strong>The strongest associations were between ICM-MM and PRSTRAIT for depression and type 2 diabetes-both odds ratios (OR) 1.18, [95% confidence interval (CI) 1.17-1.20] per standard deviation increase in PRSTRAIT. ICM-MM-PRSTRAIT retained five PRSTRAIT, with stronger associations (OR = 1.31, [95%CI 1.29-1.34]) than any PRSTRAIT in the testing sample.</p><p><strong>Discussion: </strong>Combining several PRS explains more variance in ICM-MM liability than single-trait PRSs alone. ICM-MM-PRSTRAIT is a measure of genetic risk that could be used to examine premorbid stages of ICM-MM in external and youth cohorts, supporting awareness of earlier presentation and potentially avoidance or intervention.</p>","PeriodicalId":13070,"journal":{"name":"Human molecular genetics","volume":"35 7","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13116345/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human molecular genetics","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/hmg/ddag012","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multimorbidity, also known as multiple long-term conditions, is a major public health concern. Internalising and CardioMetabolic MultiMorbidity (ICM-MM) is a common form of mental-physical health multimorbidity, yet its genetic predisposition is largely unknown. We examined the polygenic nature of ICM-MM by assessing single trait-specific polygenic risk scores (PRSTRAIT) and whether combining them could increase the proportion of variance in liability to ICM-MM explained by genetic variation.

Methods: We developed PRSTRAIT using PRS-CS and summary statistics from the largest trait-specific GWAS excluding UK Biobank (UKB). We evaluated PRSTRAIT on ICM-MM risk in 206 452 UKB participants (n = 39 311 (19.0%) with ICM-MM) using logistic regression adjusted for gender and 10 genetic principal components, defining ICM-MM as lifetime occurrence of: ≥1 internalising (depression, anxiety, somatoform disorder) traits AND ≥ 1 cardiometabolic traits (type 2 diabetes, obesity, hypertension, dyslipidemia, chronic kidney disease). We used elastic net regression in a 50% training sample to generate ICM-MM-PRSTRAIT: a weighted combination of PRSTRAIT targeting ICM-MM.

Results: The strongest associations were between ICM-MM and PRSTRAIT for depression and type 2 diabetes-both odds ratios (OR) 1.18, [95% confidence interval (CI) 1.17-1.20] per standard deviation increase in PRSTRAIT. ICM-MM-PRSTRAIT retained five PRSTRAIT, with stronger associations (OR = 1.31, [95%CI 1.29-1.34]) than any PRSTRAIT in the testing sample.

Discussion: Combining several PRS explains more variance in ICM-MM liability than single-trait PRSs alone. ICM-MM-PRSTRAIT is a measure of genetic risk that could be used to examine premorbid stages of ICM-MM in external and youth cohorts, supporting awareness of earlier presentation and potentially avoidance or intervention.

结合多基因风险评分,了解英国生物银行生理和心理健康多重疾病的遗传倾向性。
背景:多重疾病,又称多重长期疾病,是一个主要的公共卫生问题。内化和心脏代谢多病(ICM-MM)是一种常见的精神-身体健康多病,但其遗传易感性在很大程度上是未知的。我们通过评估单性状特异性多基因风险评分(PRSTRAIT)来检验ICM-MM的多基因性质,以及将它们结合起来是否会增加遗传变异解释的ICM-MM的责任变异比例。方法:我们利用PRS-CS和除UK Biobank (UKB)外最大的性状特异性GWAS的汇总统计数据开发了PRSTRAIT。我们评估了PRSTRAIT对206452名UKB参与者(n = 39311(19.0%)患有ICM-MM)的ICM-MM风险,使用经性别和10个遗传主成分调整的logistic回归,将ICM-MM定义为一生中发生≥1种内化(抑郁、焦虑、躯体形式障碍)特征和≥1种心脏代谢特征(2型糖尿病、肥胖、高血压、血脂异常、慢性肾病)。我们在50%的训练样本中使用弹性网络回归来生成ICM-MM-PRSTRAIT:一个针对ICM-MM的PRSTRAIT加权组合。结果:ICM-MM和PRSTRAIT对抑郁症和2型糖尿病的相关性最强——PRSTRAIT每标准差增加的比值比(OR)均为1.18,[95%可信区间(CI) 1.17-1.20]。ICM-MM-PRSTRAIT保留了5个PRSTRAIT,与测试样本中的任何PRSTRAIT相比,它们的相关性更强(OR = 1.31, [95%CI 1.29-1.34])。讨论:结合几个PRS比单独的单一特征PRS更能解释ICM-MM责任的差异。ICM-MM- prstrait是一种遗传风险测量方法,可用于检查外部和青年人群中ICM-MM的发病前阶段,支持对早期表现和潜在避免或干预的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human molecular genetics
Human molecular genetics 生物-生化与分子生物学
CiteScore
6.90
自引率
2.90%
发文量
294
审稿时长
2-4 weeks
期刊介绍: Human Molecular Genetics concentrates on full-length research papers covering a wide range of topics in all aspects of human molecular genetics. These include: the molecular basis of human genetic disease developmental genetics cancer genetics neurogenetics chromosome and genome structure and function therapy of genetic disease stem cells in human genetic disease and therapy, including the application of iPS cells genome-wide association studies mouse and other models of human diseases functional genomics computational genomics In addition, the journal also publishes research on other model systems for the analysis of genes, especially when there is an obvious relevance to human genetics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书